Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Acta Neurologica Belgica|January 30, 2022
Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19Fereshteh Ghadiri, Abdorreza Naser Moghadasi, Mohammad Ali Sahraian
Multiple Sclerosis and Related Disorders|September 24, 2022
Gut microbiome in multiple sclerosis-related cognitive impairmentFereshteh Ghadiri, Zahra Ebadi, Elnaz Asadollahzadeh, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
The study of COVID-19 infection following vaccination in patients with multiple sclerosisFereshteh Ghadiri, Mohammad Ali Sahraian, Amirreza Azimi, et al.
Vaccine|September 28, 2021
Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorVMohammad Ali Sahraian, Fereshteh Ghadiri, Amirreza Azimi, et al.
Current Journal of Neurology|November 27, 2023
The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccineFereshteh Ghadiri, Mohammad Ali Sahraian, Amirreza Azimi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2012
Breast cancer research in Iran; essential data to organize researchAhmad Kaviani, Fereshteh Ghadiri, Negar Iranpour, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 3, 2013
Do the different reasons for lactation discontinuation have similar impact on future breast problems?Fereshteh Ghadiri, Negar Iranpour, Masud Yunesian, et al.
Current Journal of Neurology|November 27, 2023
The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorderNasim Rezaeimanesh, Roghayyeh Saeedi, Mohammad Ali Sahraian, et al.
Current Journal of Neurology|November 27, 2023
Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic reviewFereshteh Ghadiri, Omid Mirmosayyeb, Mohammad Ali Sahraian, et al.
Multiple Sclerosis and Related Disorders|October 7, 2019
Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational studyAbdorreza Naser Moghadasi, Aala Darki, Peiman Masoumi, et al.
Pageof 3